On the next screen, browse for “Quest Diagnostics” using the search bar. When you see Quest Diagnostics as the parent laboratory, click on the “+” to bring up a list of all Quest facilities. Select any facility to open a page of general lab details. On the lab details page, click...
Ordering from a Quest Diagnostics affiliate? CLICK HERE SELECT SERVICE AREANOT NOW Our Test Directory includes detailed information, guides and references for many of our tests. This includes test and result codes, specimen collection requirements, specimen transport considerations, and methodology. ...
Make timely and informed lab decisions—with data and analytics solutions, lab stewardship, and medical insight Improve service levels—with an efficient infrastructure built to serve your needs and drive quality results By supporting standard and advanced diagnostics needs and providing tools and services...
Quest Diagnostics offers advanced hereditary cancer risk testing so that you and your patients can understand the potential risk for cancer, and in some cases, inform treatment and prognosis. From comprehensive panels to single-gene tests, our complete portfolio of hereditary cancer tests delivers acce...
If you're interested to learn more about Quest Diagnostics' offerings as a preferred laboratory network provider, contact us by submitting an online form.
"Laboratory innovation is key to optimizing testing capacity for COVID-19," said Steve Rusckowski, Chairman, Chief Executive and President, Quest Diagnostics. "We appreciate the collaboration of the FDA to bring this technique to several of our labs spanning the U.S. W...
Test Directory About our tests Access patient results Billing & coding Lab tools & IT systems Clinical experts & education Quest Diagnostics Healthcare professionals Clinical Education Center FAQ Hypogonadism HypogonadismTest codes: 457, 470, 509, 571, 615, 746, 866, 899, 873, 4212, 5363, 5616,...
The US contract research organization Quintiles and Quest Diagnostics , a US provider of diagnostic information services, have announced a definitive agreement to form a global clinical trials laboratory services business. According to the two companies, the new joint venture will ...
Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced that its AAVrh74 ELISA assay (CDx) has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).
Quest Diagnostics是美国,也是全球最大的医疗检验服务提供商之一,当前市值138亿美金(约990亿人民币),拥有着丰富而引人入胜的发展历程。 Quest是全球ICL(第三方医学检验实验室)的风向标,也启发了中国ICL企业的发展,中国以金域、迪安为代表的ICL企业,无一不受到Quest的深刻影响。除了Quest以外,美国还有另一大第三方检验...